Biogen Q4 revenue drops 4% YoY to land at $2.73B

Thursday, 03. February 2022 13:07

American biotechnology firm Biogen Inc. revealed on Thursday its revenue in the fourth quarter of 2021 landed at $2.73 billion, down by 4% in comparison to the same period last year. Its GAAP net income stood at $368 million, an increase of 2.87% year-on-year, while its diluted earnings per share (EPS) came in at $2.5, a 7.75% rise from the $2.32 reported in the third trimester of 2020.

On an annual level, Biogen's revenues landed at $10.98 billion, recording an 18.3% drop year-over-year, while its total yearly net income came at $1.55 billion, falling by 61.25% compared to 2020. Furthermore, the company's diluted EPS amounted to $10.40, a considerable 58.06% decrease in comparison to its 2020 results.

“Biogen continued to execute well in the fourth quarter despite the challenges we have faced,” said Michel Vounatsos, Biogen's Chief Executive Officer.

Related Links: Biogen Inc.
Baha Breaking News (BBN) / SP